Clinical Trial Details
| Trial ID: | L1958 |
| Source ID: | NCT00592527 |
| Associated Drug: | Insulin Detemir |
| Title: | Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: insulin detemir |
| Outcome Measures: | Primary: HbA1c, after 20 weeks of treatment | Secondary: Fasting plasma glucose (FPG)|Within-subject variation|Change in body weight|Incidence of adverse events |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 132 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2004-04 |
| Completion Date: | 2004-12 |
| Results First Posted: | |
| Last Update Posted: | 2017-01-27 |
| Locations: | Novo Nordisk Investigational Site, Kochi, Kerala, 682041, India|Novo Nordisk Investigational Site, Ahmedabad, 390009, India|Novo Nordisk Investigational Site, Chennai, 600-013, India|Novo Nordisk Investigational Site, Chennai, 600010, India|Novo Nordisk Investigational Site, Nagpur, 440012, India |
| URL: | https://clinicaltrials.gov/show/NCT00592527 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|